Effects of intramammary infusion of cis-urocanic acid on mastitis-associated inflammation and tissue injury in dairy cow

American Journal of Veterinary Research

Volumn 70, Issue 3, 2009, Pages 373-382

  Bannerman, Douglas D ^a,c   Rinaldi, Manuela ^a   Vinyard, Bryan T ^a   Laihia, Jarmo ^b   Leino, Lasse ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b BioCis Pharma Ltd   (Finland)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CATTLE DISEASE; CONTROLLED STUDY; DAIRY CATTLE; DRUG DOSE COMPARISON; DRUG MILK LEVEL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; INFLAMMATION; MASTITIS; NONHUMAN; TISSUE INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; INFLAMMATION; MASTITIS, BOVINE; TIME FACTORS; UROCANIC ACID;

ANIMALIA; BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI;

EID: 63249136768     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.3.373     Document Type: Article

References (71)

1. Wells SJ, Ott SL, Seitzinger AH. Key health issues for dairy cattle - new and old. J Dairy Sci 1998;81:3029-3035.
2. Wellenberg GJ, van der Poel WH, Van Oirschot JT. Viral infections and bovine mastitis: a review. Vet Microbiol 2002;88:27-45.
3. Bascom SS, Young AJ. A summary of the reasons why farmers cull cows. J Dairy Sci 1998;81:2299-2305.
4. Bradley A. Bovine mastitis: an evolving disease. Vet J 2002;164:116-128.
5. Hillerton JE, Bramley AJ, Staker RT, et al. Patterns of intramammary infection and clinical mastitis over a 5 year period in a closely monitored herd applying mastitis control measures. J Dairy Res 1995;62:39-50.
6. Makovec JA, Ruegg PL. Results of milk samples submitted for microbiological examination in Wisconsin from 1994 to 2001. J Dairy Sci 2003;86:3466-3472.
7. Barkema HW, Schukken YH, Lam TJ, et al. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J Dairy Sci 1998;81:411-419.
8. Wilson DJ, Gonzalez RN, Das HH. Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production. J Dairy Sci 1997;80:2592-2598.
9. Bradley AJ, Green MJ. Aetiology of clinical mastitis in six Somerset dairy herds. Vet Rec 2001;148:683-686.
10. Hazlett MJ, Little PB, Maxie MG, et al. Fatal mastitis of dairy cows: a retrospective study. Can J Comp Med 1984;48:125-129.
11. Wilesmith JW, Francis PG, Wilson CD. incidence of clinical mastitis in a cohort of British dairy herds. Vet Rec 1986;118:199-204.
12. Hogan JS, Smith KL, Todhunter DA, et al. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine. J Dairy Sci 1992;75:78-84.
13. Hogan JS, Weiss WP, Todhunter DA, et al. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial. J Dairy Sci 1992;75:415-422.
14. Tomita GM, Ray CH, Nickerson SC, et al. A comparison of two commercially available Escherichia coli J5 vaccines against E coli intramammary challenge. J Dairy Sci 2000;83:2276-2281.
15. Hill AW. Vaccination of cows with rough Escherichia coli mutants fails to protect against experimental intramammary bacterial challenge. Vet Res Commun 1991;15:7-16.
16. Erskine RJ, Tyler JW, Riddell MG Jr, et al. Theory, use, and realities of efficacy and food safety of antimicrobial treatment of acute coliform mastitis. J Am Vet Med Assoc 1991;198:980-984.
17. Bannerman DD, Paape MJ, Lee JW, et al. Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin Diagn Lab Immunol 2004;11:463-472.
18. Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 2001;99:7-17.
19. Gudmundsson GH, Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods 1999;232:45-54.
20. Fantone JC, Ward PA. Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease. Hum Pathol 1985;16:973-978.
21. Ricevuti G. Host tissue damage by phagocytes. Ann N Y Acad Sci 1997;832:426-448.
22. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
23. Capuco AV, Paape MJ, Nickerson SC. In vitro study of polymorphonuclear leukocyte damage to mammary tissues of lactating cows. Am J Vet Res 1986;47:663-668.
24. Long E, Capuco AV, Wood DL, et al. Escherichia coli induces apoptosis and proliferation of mammary cells. Cell Death Differ 2001;8:808-816.
25. Lauzon K, Zhao X, Bouetard A, et al. Antioxidants to prevent bovine neutrophil-induced mammary epithelial cell damage. J Dairy Sci 2005;88:4295-4303.
26. Ledbetter TK, Paape MJ, Douglass LW. Cytotoxic effects of peroxynitrite, polymorphonuclear neutrophils, free-radical scavengers, inhibitors of myeloperoxidase, and inhibitors of nitric oxide synthase on bovine mammary secretory epithelial cells. Am J Vet Res 2001;62:286-293.
27. Boulanger V, Zhao X, Lacasse P. Protective effect of melatonin and catalase in bovine neutrophil-induced model of mammary cell damage. J Dairy Sci 2002;85:562-569.
28. Bogin E, Ziv G. Enzymes and minerals in normal and mastitic milk. Cornell Vet 1973;63:666-676.
29. Chagunda MG, Larsen T, Bjerring M, et al. L-lactate dehydrogenase and N-acetyl-beta-D-glucosaminidase activities in bovine milk as indicators of non-specific mastitis. J Dairy Res 2006;73:431-440.
30. Kitchen BJ, Kwee WS, Middleton G, et al. Relationship between the level of N-acetyl-beta-D-glucosaminidase (NAGase) in bovine milk and the presence of mastitis pathogens. J Dairy Res 1984;51:11-16.
31. Mattila T, Pyorala S, Sandholm M. Comparison of milk antitrypsin, albumin, n-acetyl-beta-D-glucosaminidase, somatic cells and bacteriological analysis as indicators of bovine subclinical mastitis. Vet Res Commun 1986;10:113-124.
32. Lauzon K, Zhao X, Lacasse P. Deferoxamine reduces tissue damage during endotoxin-induced mastitis in dairy cows. J Dairy Sci 2006;89:3846-3857.
33. Norval M, El-Ghorr AA. Studies to determine the immumomodulating effects of cis-urocanic acid. Methods 2002;28:63-70.
34. Hart PH, Jaksic A, Swift G, et al. Histamine involvement in UVB- and cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses. Immunology 1997;91:601-608.
35. Holan V, Kuffova L, Zajicova A, et al. Urocanic acid enhances IL-10 production in activated CD4+ T cells. J Immunol 1998; 161:3237-3241.
36. Gruner S, Diezel W, Stoppe H, et al. inhibition of skin allograft rejection and acute graft-versus-host disease by cis-urocanic acid. J Invest Dermatol 1992;98:459-462.
37. Guymer RH, Mandel TE. Urocanic acid as an immunosuppressant in allotransplantation in mice. Transplantation 1993;55:36-43.
38. Gilmour JW, Vestey JP, George S, et al. Effect of phototherapy and urocanic acid isomers on natural killer cell function. J Invest Dermatol 1993;101:169-174.
39. Hart PH, Jones CA, Jones KL, et al. Cis-urocanic acid stimulates human peripheral blood monocyte prostaglandin E2 production and suppresses indirectly tumor necrosis factor-alpha levels. J Immunol 1993;150:4514-4523.
40. Kivisto K, Punnonen K, Toppari J, et al. Urocanic acid suppresses the activation of human neutrophils in vitro. Inflammation 1996;20:451-459.
41. Rinaldi M, Moroni P, Leino L, et al. Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species. J Dairy Sci 2006;89:4188-4201.
42. Bramley AJ. Variations in the susceptibility of lactating and non-lactating bovine udders to infection when infused with Escherichia coli. J Dairy Res 1976;43:205-211.
43. Bannerman DD, Paape MJ, Hare WR, et al. Increased levels of LPS-binding protein in bovine blood and milk following bacterial lipopolysaccharide challenge. J Dairy Sci 2003;86:3128-3137.
44. Mattila T, Sandholm M. Antitrypsin and N-acetyl-beta-D-glucosaminidase as markers of mastitis in a herd of Ayshire cows. Am J Vet Res 1985;46:2453-2456.
45. Littell RC, Milliken GA, Stroup WW, et al. Case studies. In: SAS for mixed models. 2nd ed. Cary, NC: SAS Institute Inc, 2006;699-716.
46. Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood 1984;64:959-966.
47. Chockalingam A, Paape MJ, Bannerman DD. Increased milk levels of transforming growth factor-alpha, beta1, and beta2 during Escherichia coli-induced mastitis. J Dairy Sci 2005;88:1986-1993.
48. Nagahata H. Bovine leukocyte adhesion deficiency (BLAD): a review. J Vet Med Sci 2004;66:1475-1482.
49. Schalm OW Lasmanis J, Jain NC. Conversion of chronic staphylococcal mastitis to acute gangrenous mastitis after neutropenia in blood and bone marrow produced by an equine anti-bovine leukocyte serum. Am J Vet Res 1976;37:885-890.
50. Vandeputte-Van Messom G, Burvenich C, Roets E, et al. Classification of newly calved cows into moderate and severe responders to experimentally induced Escherichia coli mastitis. J Dairy Res 1993; 60:19-29.
51. Shuster DE, Lee EK, Kehrli ME Jr. Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation. Am J Vet Res 1996;57:1569-1575.
52. Saad AM, Ostensson K. Flow cytofluorometric studies on the alteration of leukocyte populations in blood and milk during endotoxin-induced mastitis in cows. Am J Vet Res 1990;51:1603-1607.
53. Kauf AC, Vinyard BT, Bannerman DD. Effect of intramammary infusion of bacterial lipopolysaccharide on experimentally induced Staphylococcus aureus intramammary infection. Res Vet Sci 2007;82:39-46.
54. Riollet C, Rainard P, Poutrel B. Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus. Clin Diagn Lab Immunol 2000;7:161-167.
55. Rainard P. The complement in milk and defense of the bovine mammary gland against infections. Vet Res 2003;34:647-670.
56. Laihia JK, Jansen CT, Uksila J, et al. Effects of cis- and trans-urocanic acids on the secretion of interleukin-1 beta and tumour necrosis factor-alpha by human peripheral blood monocytes. Acta Derm Venereol 1994;74:266-268.
57. Redondo P, Garcia-Foncillas J, Cuevillas F, et al. Effects of low concentrations of cis- and trans-urocanic acid on cytokine elaboration by keratinocytes. Photodermatol Photoimmunol Photomed 1996;12:237-243.
58. Wilson DJ, Bartlett PC, Kirk JH, et al. N-acetyl-beta-D-glucosaminidase as a predictor of milk loss and recovery after clinical mastitis. Am J Vet Res 1991;52:1110-1116.
59. Zank W, Schlatterer B. Assessment of subacute mammary inflammation by soluble biomarkers in comparison to somatic cell counts in quarter milk samples from dairy cows. Zentralbl Veterinarmed [A] 1998;45:41-51.
60. Pyorala S. Indicators of inflammation in the diagnosis of mastitis. Vet Res 2003;34:565-578.
61. Fox LK, Hancock DD, McDonald JS, et al. N-acetyl-beta-D-glucosaminidase activity in whole milk and milk fractions. J Dairy Sci 1988;71:2915-2922.
62. Fox LK, Timms LL, Schultz LH. Changes in bovine milk secretion following intramammary infusions of concanavalin A, oyster glycogen, or water. J Dairy Sci 1986;69:1259-1269.
63. Kitchen BJ, Middleton G, Salmon M. Bovine milk N-acetyl-beta-D-glucosaminidase and its significance in the detection of abnormal udder secretions. J Dairy Res 1978;45:15-20.
64. Obara Y, Komatsu M. Relationship between N-acetyl-beta-D-glucosaminidase activity and cell count, lactose, chloride, or lactoferrin in cow milk. J Dairy Sci 1984;67:1043-1046.
65. Piccinini R, Binda E, Belotti M, et al. Evaluation of milk components during whole lactation in healthy quarters. J Dairy Res 2007;74:226-232.
66. Drent M, Cobben NA, Henderson RF, et al. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 1996;9:1736-1742.
67. Bogin E, Ziv G, Avidar J, et al. Distribution of lactate dehydrogenase isoenzymes in normal and inflamed bovine udders and milk. Res Vet Sci 1977;22:198-200.
68. Symons DB, Wright LJ. Changes in bovine mammary gland permeability after intramammary exotoxin infusion. J Comp Pathol 1974;84:9-17.
69. Kitchen BJ, Middleton G, Durward IG, et al. Mastitis diagnostic tests to estimate mammary gland epithelial cell damage. J Dairy Sci 1980;63:978-983.
70. Wilson DJ, Herer PS, Sears PM. N-acetyl-beta-D-glucosaminidase, etiologic agent, and duration of clinical signs for sequential episodes of chronic clinical mastitis in dairy cows. J Dairy Sci 1991;74:1539-1543.
71. Rasanen L, Jansen CT, Hyoty H, et al. Cis-urocanic acid stereo-specifically modulates human monocyte IL-1 production and surface HLA-DR antigen expression, T-cell IL-2 production and CD4/CD8 ratio. Photodermatol 1989;6:287-292.